Skip to main content
. 2016 Apr 4;7(19):27988–27999. doi: 10.18632/oncotarget.8569

Figure 1. eNOS haplotypes and clinical outcome in the two independent cohorts.

Figure 1

A-C. Progression-free survival (PFS) and B-D. overall survival (OS) in relation to eNOS haplotypes (HT) in the training and validation cohorts. Other, haplotypes other than the one indicated.